Astellas US LLC et al v. Aurobindo Pharma Limited > Summary
Court Case Number 1:21-cv-01269
Filing Date Sep 3, 2021
Termination Date May 31, 2022
Court Delaware District Court
Status Dismissed - Voluntarily
JudgesColm F. Connolly
Defendant
Plaintiff Attorneys
6Astellas US LLC
Attorney Name: Kelly A. Del Dotto
Fish & Richardson
Astellas Pharma Inc.
Attorney Name: Kelly A. Del Dotto
Fish & Richardson
Gilead Sciences
Attorney Name: Kelly A. Del Dotto
Fish & Richardson
Astellas US LLC
Attorney Name: Kelly A. Del Dotto
Astellas Pharma Inc.
Attorney Name: Kelly A. Del Dotto
Gilead Sciences
Attorney Name: Kelly A. Del Dotto
Defendant Attorneys
6Aurobindo Pharma
Attorney Name: Timothy H. Kratz
Kratz & Barry
Aurobindo Pharma
Attorney Name: Touhey Myer
Kratz & Barry
Aurobindo Pharma
Attorney Name: Timothy H. Kratz
Aurobindo Pharma
Attorney Name: Touhey Myer
Attorney Name: Cortlan S. Hitch
Attorney Name: Kenneth L. Dorsney
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| RE047301 | Process for preparing an A2A-adenosine receptor agonist and its polymorphs | Mar 19, 2019 |
| 09085601 | Process for preparing an A2A-adenosine receptor agonist and its polymorphs | Jul 21, 2015 |
| 08524883 | Monohydrate of (1-{9-[4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopurin-2-yl}pyrazol-4-yl)-N-methylcarboxamide | Sep 3, 2013 |
| 08106183 | Process for preparing an A2A-adenosine receptor agonist and its polymorphs | Jan 31, 2012 |
